CN103767171A - 益生菌保健护腰或腰带及制作方法 - Google Patents
益生菌保健护腰或腰带及制作方法 Download PDFInfo
- Publication number
- CN103767171A CN103767171A CN201410034529.5A CN201410034529A CN103767171A CN 103767171 A CN103767171 A CN 103767171A CN 201410034529 A CN201410034529 A CN 201410034529A CN 103767171 A CN103767171 A CN 103767171A
- Authority
- CN
- China
- Prior art keywords
- waistband
- probio
- lactobacillus
- waist support
- bifidobacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title abstract description 9
- 239000006041 probiotic Substances 0.000 title abstract description 7
- 235000018291 probiotics Nutrition 0.000 title abstract description 7
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000000463 material Substances 0.000 claims abstract description 22
- 239000002775 capsule Substances 0.000 claims abstract description 11
- 241000186660 Lactobacillus Species 0.000 claims abstract description 10
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 10
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 10
- 239000007788 liquid Substances 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims abstract description 5
- 230000000694 effects Effects 0.000 claims description 13
- 241000186000 Bifidobacterium Species 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 4
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 4
- 244000199866 Lactobacillus casei Species 0.000 claims description 4
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 4
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 4
- 229940017800 lactobacillus casei Drugs 0.000 claims description 4
- 230000001681 protective effect Effects 0.000 claims description 4
- 238000009958 sewing Methods 0.000 claims description 4
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 3
- 241000193755 Bacillus cereus Species 0.000 claims description 3
- 241000194108 Bacillus licheniformis Species 0.000 claims description 3
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims description 3
- 241000186012 Bifidobacterium breve Species 0.000 claims description 3
- 241001608472 Bifidobacterium longum Species 0.000 claims description 3
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims description 3
- 241000193171 Clostridium butyricum Species 0.000 claims description 3
- 241000194033 Enterococcus Species 0.000 claims description 3
- 241000588724 Escherichia coli Species 0.000 claims description 3
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 3
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 3
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 3
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 3
- 241000235342 Saccharomycetes Species 0.000 claims description 3
- 229940004120 bifidobacterium infantis Drugs 0.000 claims description 3
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 3
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 3
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 abstract description 12
- 235000013618 yogurt Nutrition 0.000 abstract description 4
- 210000000936 intestine Anatomy 0.000 abstract description 2
- 231100000572 poisoning Toxicity 0.000 abstract description 2
- 230000000607 poisoning effect Effects 0.000 abstract description 2
- 239000003826 tablet Substances 0.000 abstract 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 12
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 11
- 239000004310 lactic acid Substances 0.000 description 6
- 235000014655 lactic acid Nutrition 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000036737 immune function Effects 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000000711 cancerogenic effect Effects 0.000 description 3
- 231100000357 carcinogen Toxicity 0.000 description 3
- 239000003183 carcinogenic agent Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 239000002985 plastic film Substances 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000020167 acidified milk Nutrition 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000000822 natural killer cell Anatomy 0.000 description 2
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- NPOAOTPXWNWTSH-UHFFFAOYSA-N 3-hydroxy-3-methylglutaric acid Chemical class OC(=O)CC(O)(C)CC(O)=O NPOAOTPXWNWTSH-UHFFFAOYSA-N 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- FQYQMFCIJNWDQZ-CYDGBPFRSA-N Ile-Pro-Pro Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 FQYQMFCIJNWDQZ-CYDGBPFRSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- 241000186673 Lactobacillus delbrueckii Species 0.000 description 1
- 240000002605 Lactobacillus helveticus Species 0.000 description 1
- 235000013967 Lactobacillus helveticus Nutrition 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- DOFAQXCYFQKSHT-SRVKXCTJSA-N Val-Pro-Pro Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DOFAQXCYFQKSHT-SRVKXCTJSA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000005253 cladding Methods 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 231100000284 endotoxic Toxicity 0.000 description 1
- 230000002346 endotoxic effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007366 host health Effects 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- -1 iron ion Chemical class 0.000 description 1
- 108010031424 isoleucyl-prolyl-proline Proteins 0.000 description 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 1
- 229940054346 lactobacillus helveticus Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229960005010 orotic acid Drugs 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 239000003726 plant lectin Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 108010015385 valyl-prolyl-proline Proteins 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
Images
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
益生菌保健护腰或腰带及制作方法。巴尔干半岛保加利亚地区居民日常生活中饮用的酸奶中含有大量的乳酸菌，这些乳酸菌能够定殖在人体内，有效地抑制有害细菌的生长，减少由于肠内有害菌产生的毒素对整个机体的毒害。益生菌保健护腰或腰带，其组成包括:腰带或者护腰的本体，腰带或者护腰内镶嵌一组含有益生菌及其代谢物的承载片、所述的承载片附带液体，粉末，或者为片剂或胶囊，朝向人体一侧采用透皮材料。本发明用做益生菌保健品。
Description
技术领域：
本发明提供一种益生菌保健护腰或腰带及其制作方法。
背景技术：
20世纪初诺贝尔奖获得者，俄国的免疫学大师——梅契尼可（Metchnikoff,1845-1916）在“长寿学说”中指出，巴尔干半岛保加利亚地区居民日常生活中饮用的酸奶中含有大量的乳酸菌，这些乳酸菌能够定殖在人体内，有效地抑制有害细菌的生长，减少由于肠内有害菌产生的毒素对整个机体的毒害。这里的乳酸菌其实是益生菌的一种。1965年第一次提出益生菌概念, 指添加于动物饲料中有助于肠道菌丛平衡并促进动物生长的物质或微生物。
发明内容：
本发明提供了一种简单有效的保健腰带，腰带内镶嵌含有益生菌及其代谢物的物料，人群只要正常系上腰带，就能起到保健作用。
本发明的目的是这样实现的：
益生菌保健护腰或腰带，其组成包括:腰带或者护腰的本体，腰带或者护腰内镶嵌一组含有益生菌及其代谢物的承载片、所述的承载片附带液体，粉末，或者为片剂或胶囊，朝向人体一侧采用透皮材料。
所述的益生菌保健护腰或腰带，所述的承载片或者片剂或者胶囊固定在所述的腰带内的内胆上，所述的腰带或者护腰的本体一端具有弹性段。
所述的益生菌保健护腰或腰带，所述的透皮材料上具有成组的通孔，一般3-4排，每排4-10个孔，孔径在2-10毫米，孔的边沿具有缝合线，缝合密度每吋22-26针。
所述的益生菌保健护腰或腰带，所述的益生菌包括应用于人体的益生菌有双歧杆菌、乳杆菌、肠球菌、大肠杆菌、枯草杆菌、蜡样芽孢杆菌、地衣芽孢杆菌、丁酸梭菌和酵母菌，特指两大类乳酸菌群：一类为双歧杆菌包括婴儿双歧杆菌，长双歧杆菌，短双歧杆菌，青春双歧杆菌；另一类为乳杆菌包括如嗜酸乳杆菌，干酪乳杆菌，鼠李糖乳杆菌，植物乳杆菌和罗伊氏乳杆菌。
所述的益生菌保健护腰或腰带的制作方法，选择具有透皮效果的材料，将承载片或者片剂或者胶囊固定在透皮材料上，对对外的保护面层缝合固定。
有益效果：
1.本发明采用益生菌，抗肿瘤作用是由于益生菌的存在及其生成的代谢产物优化了肠道菌群的组合，增强了免疫功能，抑制了肿瘤细胞的增殖和致癌物质的产生。
对益生菌的抗癌研究显示,嗜酸乳杆菌、干酪乳杆菌、德氏乳杆菌、保加利亚乳杆菌的菌体或用其做成的酸奶食用后可活化单球巨噬细胞的活性,增强全身性免疫应答。益生菌具有阻碍结肠和其他器官中发生的非基因型和基因突变型的功能。
动物试验说明双歧杆菌能激活机体的吞噬细胞的吞噬活性，促进特异性和非特异性IgA抗体的产生，增强了免疫系统的功能。提高机体抗病能力。
益生菌可以激活T细胞和NK细胞(Natural Killer Cell，自然杀伤细胞)，两者都能起到细胞杀伤作用，阻断入侵细胞。人体免疫功能会随着年龄的增长而降低,免疫系统的功能失调将带来健康问题,如过敏和炎症反应。
对益生菌的免疫效果研究表明,益生菌能通过激活巨噬细胞，增强细胞活性和增加免疫球蛋白(特别是IgA)的水平等来增强非特异性免疫和特异性免疫应答。
2.本发明采用益生菌及其代谢物，具有显著突破，益生菌的活菌细胞、死细胞或是发酵产物都具有免疫调节功能。
益生菌代谢产生的酸可促进对维生素D、钙和铁离子的吸收。研究表明益生菌可合成多种维生素，如硫胺素、核黄素、尼克酸、吡哆醇、泛酸、叶酸和维生素B12。当某些因素造成肠道菌群失调时，明显表现出维生素缺乏症。益生菌可抑制肠道中腐败细菌的繁殖，从而减少肠道中内毒素和尿素酶的含量，使血液中内毒素和氨含量下降。益生菌能使机体中某些具有抗衰老作用的酶活性升高，使衰老的物质浓度降低。益生菌在机体中代谢产生的酸，抑制了肠内腐败细菌的生长，从而减少这些细菌产生毒素和致癌物质，延缓了机体衰老过程。益生菌可以降低胆固醇,每天吃酸奶可使血清胆固醇降低;乳酸菌可产生3-羟基-3甲基戊二酸(HMG)而抑制了胆固醇合成时所必须的羟基戊二酰辅酶还原酶活性；也有人认为发酵乳中由乳清酸衍生的代谢产物可降低胆固醇浓度；或由于乳酸菌可将胆固醇有效地同化或将其捕住使之不能进人血液；膳食疗法来治疗高血压的研究很多,根据Tacano研究表明,益生菌食品能在一定程度上控制血压。其抗高血压效果在先天性高血压老鼠实验中得到证实,从啤酒酵母和瑞士乳杆菌发酵乳中分离的三肽物质(Val-Pro-Pro和Ile-Pro-Pro)具有抑制血管紧张素转移酶活性的作用。
益生菌提高食物转化率,促进人及动物生长发育;改善人体健康水平,有益菌大量增殖,产生竞争性排斥作用,控制消化道疾病;消化分解抗营养因子,如植酸、胰蛋白酶抑制因子、植物凝集素和非淀粉多糖，促进营养物质的利用；益生菌塑料，还具有延缓骨密度疏松，改善和增加正常血液细胞的功能。益生菌有改善肠道菌群结构,抑制病益生菌可粘附于肠粘膜上皮细胞，通过自身及产生代谢物和抑制物排斥致病菌。
在微环境下保持优势，并与肠道中其他细菌相互作用，调整菌群间关系，以保证肠道菌群最佳优势组合，并维持肠道菌群平衡。益生菌在体内发酵糖类，产生大量乙酸和乳酸，使环境pH、Eh下降，抑制了致病菌的生长。
益生菌能产生胞外糖苷酶，可降解肠粘膜上皮细胞的复杂多糖，而这些糖是潜在致病菌和结合细菌毒素的受体；通过酶的作用可以阻止潜在致病菌及其毒素在肠粘膜上皮细胞的粘附和侵入。
消除致癌因子,提高机体免疫力,降低胆固醇等重要的生理功效。具体叙述如下：1.维持肠道菌群平衡，治疗肠道功能紊乱；2．抗癌、抗肿瘤作用；3．增强免疫系统的功能；4．营养作用；5．控制内毒素的产生；6．延缓机体衰老；7. 降胆固醇功能；8. 抗高血压功能。
经试验确认，死菌体细胞成分或代谢产物也具有与活菌相同的生理功能,也能作用改变宿主某一部位菌群的组成, 从而产生有利于宿主健康作用。
我们利用包埋技术将益生菌添加到塑料片中，用含有益生菌的塑料片制成腰带，对志愿人群进行试戴腰带实验，发现所有实验人群的血铅和尿酸含量明显下降；参试人群中80%的实验者甘油三酯指标下降。
本发明采用的益生菌并非单一传统意义上的活性的菌体，而是益生菌及其代谢物。采用非口服方式，减少因口服引起的意外风险。腰带内镶嵌含有益生菌及其代谢物的物料，人群只要正常系上腰带，就能起到保健作用。
腰带材料采用棉质品、或皮料、或尼龙、或丝绒、或化纤等材料；在人体腰部对应于腰椎部位，镶嵌包埋了含有益生菌及其代谢物的塑料片、或陶瓷片（粉）、或胶囊、或容器内的液体，或皮具和其他载体。常规的护腰保健用品都是采用带子系在腰上，本发明一端具有弹性段，可以保证该腰带贴着皮肤，松紧适合。护腰产品还带有肩带，使用者在使用过程中感觉舒适。
本发明的腰带材料采用在人体腰部对应于腰椎部位，发热的同时，提供较好的保健效果。选用特定的针码，也就确定了缝合针的粗细，保证透皮的孔径和对承载片的固定作用。
附图说明：
附图1是本发明的结构示意图（腰带）。
附图2是本发明的另一种结构示意图（腰带）。
附图3是本发明的一种结构示意图（护腰）。
附图4是本发明的另一种结构示意图（护腰）。
具体实施方式：
实施例1：
益生菌保健护腰或腰带，其组成包括:腰带或者护腰的本体1，腰带或者护腰内镶嵌一组含有益生菌及其代谢物的承载片2、所述的承载片附带液体，粉末，或者为片剂或胶囊，朝向人体一侧采用透皮材料。
实施例2：
实施例1所述的益生菌保健护腰或腰带，所述的承载片或者片剂或者胶囊固定在所述的腰带内的内胆上，所述的腰带或者护腰的本体一端具有弹性段3，所述的护腰带有肩带4。
实施例3：
实施例1或2所述的益生菌保健护腰或腰带，所述的益生菌包括应用于人体的益生菌有双歧杆菌、乳杆菌、肠球菌、大肠杆菌、枯草杆菌、蜡样芽孢杆菌、地衣芽孢杆菌、丁酸梭菌和酵母菌，特指两大类乳酸菌群：一类为双歧杆菌包括婴儿双歧杆菌，长双歧杆菌，短双歧杆菌，青春双歧杆菌；另一类为乳杆菌包括如嗜酸乳杆菌，干酪乳杆菌，鼠李糖乳杆菌，植物乳杆菌和罗伊氏乳杆菌。
实施例4：
实施例1或2或3所述的益生菌保健护腰或腰带的制作方法，选择具有透皮效果的材料，将承载片或者片剂或者胶囊固定在透皮材料上，所述的透皮材料上具有成组的通孔，一般3-4排，每排4-10个孔，孔径在2-10毫米，孔的边沿具有缝合线，缝合密度每吋22-26针，透皮效果的材料与对外的保护面层缝合固定。
Claims (5)
1.一种益生菌保健护腰或腰带，其组成包括:腰带或者护腰的本体，其特征是: 腰带或者护腰内镶嵌一组含有益生菌及其代谢物的承载片、所述的承载片附带液体，粉末，或者为片剂或胶囊，朝向人体一侧采用透皮材料。
2.根据权利要求1所述的益生菌保健护腰或腰带，其特征是：所述的承载片或者片剂或者胶囊固定在所述的腰带内的内胆上，所述的腰带或者护腰的本体一端具有弹性段。
3.根据权利要求1或2所述的益生菌保健护腰或腰带，其特征是：所述的透皮材料上具有成组的通孔，一般3-4排，每排4-10个孔，孔径在2-10毫米，孔的边沿具有缝合线，缝合密度每吋22-26针。
4.根据权利要求1或2或3所述的益生菌保健护腰或腰带，其特征是：所述的益生菌包括应用于人体的益生菌有双歧杆菌、乳杆菌、肠球菌、大肠杆菌、枯草杆菌、蜡样芽孢杆菌、地衣芽孢杆菌、丁酸梭菌和酵母菌，特指两大类乳酸菌群：一类为双歧杆菌包括婴儿双歧杆菌，长双歧杆菌，短双歧杆菌，青春双歧杆菌；另一类为乳杆菌包括如嗜酸乳杆菌，干酪乳杆菌，鼠李糖乳杆菌，植物乳杆菌和罗伊氏乳杆菌。
5.一种权利要求1或2或3或4所述的益生菌保健护腰或腰带的制作方法，其特征是：选择具有透皮效果的材料，，将承载片或者片剂或者胶囊固定在透皮材料上，对对外的保护面层缝合固定。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410034529.5A CN103767171A (zh) | 2014-01-24 | 2014-01-24 | 益生菌保健护腰或腰带及制作方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410034529.5A CN103767171A (zh) | 2014-01-24 | 2014-01-24 | 益生菌保健护腰或腰带及制作方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103767171A true CN103767171A (zh) | 2014-05-07 |
Family
ID=50560290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410034529.5A Pending CN103767171A (zh) | 2014-01-24 | 2014-01-24 | 益生菌保健护腰或腰带及制作方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103767171A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107495485A (zh) * | 2017-08-29 | 2017-12-22 | 蔡江峰 | 一种防辐射抗菌内衣布料生产工艺 |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2070183U (zh) * | 1990-06-06 | 1991-01-30 | 蕲春县李时珍中医药研究所 | 中药保健腰带 |
| CN2427989Y (zh) * | 2000-06-19 | 2001-05-02 | 邯郸市雪驰集团有限公司 | 保健护腰 |
| JP2002052088A (ja) * | 2000-08-08 | 2002-02-19 | Suma Maekawa | 健康バンド |
| EP1437109A1 (en) * | 2003-01-07 | 2004-07-14 | Taketora Co., Ltd. | Lumbar supporter |
| CN2896933Y (zh) * | 2006-05-24 | 2007-05-09 | 涂志龙 | 一种保健腰带 |
| CN103103798A (zh) * | 2011-11-09 | 2013-05-15 | 紫罗兰家纺科技股份有限公司 | 洁菌、益生菌抗菌加凉爽整理复合保健家居用品 |
| CN103114439A (zh) * | 2013-01-24 | 2013-05-22 | 量子高科(中国)生物股份有限公司 | 一种具有生物调节作用的无纺布及其制备方法 |
| CN203182099U (zh) * | 2013-02-01 | 2013-09-11 | 罗敏 | 药物保健护腰带 |
-
2014
- 2014-01-24 CN CN201410034529.5A patent/CN103767171A/zh active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2070183U (zh) * | 1990-06-06 | 1991-01-30 | 蕲春县李时珍中医药研究所 | 中药保健腰带 |
| CN2427989Y (zh) * | 2000-06-19 | 2001-05-02 | 邯郸市雪驰集团有限公司 | 保健护腰 |
| JP2002052088A (ja) * | 2000-08-08 | 2002-02-19 | Suma Maekawa | 健康バンド |
| EP1437109A1 (en) * | 2003-01-07 | 2004-07-14 | Taketora Co., Ltd. | Lumbar supporter |
| CN2896933Y (zh) * | 2006-05-24 | 2007-05-09 | 涂志龙 | 一种保健腰带 |
| CN103103798A (zh) * | 2011-11-09 | 2013-05-15 | 紫罗兰家纺科技股份有限公司 | 洁菌、益生菌抗菌加凉爽整理复合保健家居用品 |
| CN103114439A (zh) * | 2013-01-24 | 2013-05-22 | 量子高科(中国)生物股份有限公司 | 一种具有生物调节作用的无纺布及其制备方法 |
| CN203182099U (zh) * | 2013-02-01 | 2013-09-11 | 罗敏 | 药物保健护腰带 |
Non-Patent Citations (6)
| Title |
|---|
| 任清，付国亮: "《微生物酵素与美容保健》", 30 June 2009, 中国农业科学技术出版社 * |
| 何国庆: "《食品发酵与酿造工艺学》", 31 August 2011, 中国农业出版社 * |
| 刁治民: "《农业微生物工程学》", 31 December 2007 * |
| 张勇，刘勇，张和平: "世界益生菌产品研究和发展趋势", 《中国微生态学杂志》 * |
| 张小莺，孙建国: "《功能性食品学》", 31 August 2012, 科学出版社 * |
| 魏华，刘春梅，程波财，徐峰: "益生菌活菌与死菌的保健作用研究进展", 《食品科学》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107495485A (zh) * | 2017-08-29 | 2017-12-22 | 蔡江峰 | 一种防辐射抗菌内衣布料生产工艺 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Enujiugha et al. | Probiotic potentials of cereal-based beverages | |
| Stanton et al. | Fermented functional foods based on probiotics and their biogenic metabolites | |
| Woodmansey | Intestinal bacteria and ageing | |
| Guarner et al. | Should yoghurt cultures be considered probiotic? | |
| Valdés-Varela et al. | In vitro fermentation of different fructo-oligosaccharides by Bifidobacterium strains for the selection of synbiotic combinations | |
| US11612171B2 (en) | Food composition and pharmaceutical composition with strains of lactic acid bacteria and method for modulating blood glucose | |
| US11026983B2 (en) | Bifidobacterium breve CBT BR3 strain for promotion of growth and nutraceutical composition for promotion of growth containing the same | |
| Mishra et al. | Current trends in non-dairy based synbiotics | |
| CN106434438A (zh) | 一种高抗逆益生菌的制备方法及其应用 | |
| CN106578064B (zh) | 一种阿胶乳酸菌饮品及其制备方法 | |
| Cheng et al. | Effects of carbon and nitrogen sources on activity of cell envelope proteinase produced by Lactobacillus plantarum LP69 | |
| CN108782758A (zh) | 一种发酵型合生元羊奶粉及其制备方法 | |
| Muzaffar et al. | Commercially available probiotics and prebiotics used in human and animal nutrition | |
| WO2012036576A1 (en) | Method of production of fermented, pro-healthy, cereal beverages | |
| CN214071635U (zh) | 一种益生菌制剂的多层包埋肠定植颗粒结构 | |
| CN106617095B (zh) | 一种阿胶益生菌口服液及其制备方法 | |
| Pop et al. | Pro and prebiotics foods that modulate human health | |
| Ray | Probiotics of lactic acid bacteria: science or myth? | |
| CN112006285A (zh) | 一种靶向定植的益生菌粉及其制备方法 | |
| CN104988089A (zh) | 一种鸡用益生菌菌制剂及其制备方法 | |
| Kabeir et al. | Survival of Bifidobacterium pseudocatenulatum G4 during the storage of fermented peanut milk (PM) and skim milk (SM) products | |
| KR101591978B1 (ko) | 항당뇨 및 항고지혈증 활성을 갖는 락토바실러스 브레비스 jb pml-127 균주 및 이의 용도 | |
| JP2007028920A (ja) | 発酵乳およびその製造方法 | |
| Agagündüz et al. | Novel Candidate Microorganisms for Fermentation Technology: From Potential Benefits to Safety Issues. Foods 2022, 11, 3074 | |
| KR101581826B1 (ko) | 항당뇨 및 항고지혈증 활성을 갖는 락토바실러스 브레비스 jb pml-131 균주 및 이의 용도 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140507 |
|
| WD01 | Invention patent application deemed withdrawn after publication |